Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Zomax IV*


Contraindicated

Contraindicated
Zomax IV* :
Type Medicine Non Marketed
Originator Zithromax IV*
Agent Droguerie de l'Union
Distributor Droguerie de l'Union
Laboratory Hikma Pharmaceuticals
Responsible Party Hikma Pharmaceuticals
Origin Jordan
Manufacturer Hikma Italia SPA
Manufacturing Type G
Origin Italy
ATC J01FA10

Your comment will appear shortly after approval

Zomax IV* :

Revision Date : 01/02/2016


Effect Frequency
Abdominal pain Common
Ageusia (Taste loss) Not known
Aggressive reaction Not known
Agitation Not known
Alkaline phosphatase serum increased Not known
ALT increased Not known
Anaphylaxis Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Anorexia Common
Anosmia (smell loss) Not known
Anxiety Not known
Arrhythmia Not known
Arthralgia (Pain joint) (Joint ache) Not known
AST increased Not known
Asthenia Not known
Blood bilirubin increased Not known
Bronchospasm Uncommon
Constipation Not known
Convulsion Not known
Creatinine increased Not known
Deafness Not known
Diarrhoea (Diarrhea) Common
Dizziness Not known
DRESS (Drug reaction with eosinophilia and systemic symptoms) Not known
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Uncommon
Dyspepsia Uncommon
Erythema multiforme Not known
Fatigue Not known
Flatulence Uncommon
Gastritis Uncommon
Headache Uncommon
Hearing impaired Not known
Hearing loss Not known
Hepatic failure (Hepatic insufficiency) (Liver failure) Not known
Hepatic necrosis Not known
Hepatitis Not known
Hyperactivity (Increased activity) Not known
Hypotension Not known
Injection site inflammation Common
Injection site pain Common
Interstitial nephritis Not known
Jaundice cholestatic (Cholestatic icterus) Not known
LDL Increased Not known
Leucopenia (Leukopenia) Not known
Liver function test abnormal Not known
Loose stools (Soft stools) Common
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Malaise Not known
Mucositis Uncommon
Nausea Very Common
Nervousness Not known
Neutropenia Not known
Oedema Not known
Oral candidiasis Not known
Oral moniliasis Uncommon
Pancreatitis Not known
Paraesthesia (paresthesia) Not known
Parosmia Not known
Platelet count decreased (Thrombocyte count decreased) Not known
Pruritus Common
Pseudomembranous colitis Not known
Pyloric stenosis Not known
QT interval prolonged (QT prolongation) Not known
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) Not known
Skin rash Common
Somnolence Uncommon
Stevens-Johnson syndrome Not known
Syncope Not known
Thrombocytopenia (Thrombopenia) Not known
Tinnitus Not known
Tongue discolouration Not known
Torsade de pointes Not known
Urticaria Not known
Vaginitis Common
Ventricular tachycardia Not known
Vertigo Not known
Vomiting Common

Different Units By MoH Code

Revision Date : 01/09/2005

Zomax IV*  MoH 5287 :
Form Powder for solution for injection
Packaging Bottle
Package Size Box of 1
Strength 500mg
NSSF ✘
Quarantine ✘
Reg. Number 24665/07
Submission date 01/01/2007
Registration Year 2009
Archived Date 2017


Price Comparison

● Country: Jordan
● Package Size: 1
● Public Price: 8.5 JOD ( 1,064,378.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 8,5 JOD ( 1,001,768.00 LBP )
● Reference: JFDA
● Pricing Date: 25/05/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info